13th World Congress on Pain (IASP) in Montreal, Quebec, Canada, Aug./Sept. 2010

We (HPR) had a poster presentation at the 13th IASP World Congress on Pain in Montreal, Quebec, Canada (Aug./Sept. 2010) – in cooperation with Abbott Laboratories, Chicago, USA – with the following title (please contact us, for sending a poster PDF-file – if convenient – or have a look here Poster_LEP_IASP 2010):

Title: “Effects of a Novel TRPV1 Antagonist ABT-102 in a Human Experimental Pain Study Using Laser Somatosensory Evoked Potentials Obtained from UVB-Irritated and Normal Skin in Healthy Volunteers”

Klaus Schaffler, W. Rachel Duan, Andrea E. Best, Connie R. Faltynek, Charles Locke, Wolfram Nothaft

About Klaus Schaffler

Dr. med. Klaus Schaffler (MD) has been specializing in the electrophysiology and pharmacology of the human central nervous system (CNS) – as well as in the field of human experimental pain research. During this development process, HPR Dr. Schaffler GmbH has issued over 175 presentations/ publications (sharing more than 50 on pain/ analgesia) and has conducted more than 150 phase-I studies with quite different objectives.
This entry was posted in Clinical Studies. Bookmark the permalink.